RSSCategory: Biotechnology

Can machines really tell us if we’re sick?

Can machines really tell us if we’re sick?

By Anton van den Hengel, Professor of Computer Science University of Adelaide, Australia Researchers have built an algorithm that can classify skin lesions as cancerous or benign with the same accuracy as dermatologists. This week US scientists announced they have developed an algorithm, or a computerised tool, to identify skin cancers through analysis of photographs. Rather […]

January 27, 2017 | By | Reply More
Should scientists ask your permission to study your blood and tissues?

Should scientists ask your permission to study your blood and tissues?

The privacy debate over research with your blood and tissue – Viewpoint Kayte Spector-Bagdady, Research Investigator, Obstetrics and Gynecology University of Michigan Many people don’t realize that their leftover tissue, blood or other samples – otherwise known as “biospecimens” – taken during a visit to the doctor or hospital might be stripped of identifying information […]

January 27, 2017 | By | Reply More
Trump’s HHS pick favored drugmakers, device makers and doctors

Trump’s HHS pick favored drugmakers, device makers and doctors

By Christina Jewett and Marisa Taylor Kaiser Health News As Cabinet nominee Tom Price faces a Senate confirmation hearing Tuesday, a newly released trove of documents sheds further light on how he interacted as a congressman with the Centers for Medicare and Medicaid, the massive agency he may soon oversee. Letters provided by CMS after […]

January 23, 2017 | By | Reply More
When study cast doubt on heart pill, the drug company turned to Tom Price

When study cast doubt on heart pill, the drug company turned to Tom Price

By Robert Faturechi ProPublica, Jan. 19, 2017 The $3 pill known as BiDil was already a difficult sell when a Georgia-based pharmaceutical company bought the marketing rights a few years ago. A treatment for African Americans suffering from heart failure, BiDil had never really caught on, forcing the drug company that developed it to take […]

January 20, 2017 | By | Reply More
Life Science Washington appoints Martin Simonetti as board chair

Life Science Washington appoints Martin Simonetti as board chair

Board expands to include new representatives from Adaptive Biotechnologies, Bill & Melinda Gates Foundation, Celgene and M3 Biotechnology and other industry leaders SEATTLE – Jan. 16, 2017 – Life Science Washington, the state’s life science trade association, today announced the election of Martin Simonetti as chairman of the board, as the board expands to welcome […]

January 18, 2017 | By | Reply More
Pharma money reaches guidelines writers, patient groups — even doctors on Twitter

Pharma money reaches guidelines writers, patient groups — even doctors on Twitter

By Charles Ornstein ProPublica, Jan. 17, 2017 The long arm of the pharmaceutical industry continues to pervade practically every area of medicine, reaching those who write guidelines that shape doctors’ practices, patient advocacy organizations, letter writers to the Centers for Disease Control and Prevention, and even oncologists on Twitter, according to a series of papers […]

January 18, 2017 | By | Reply More
Sky-high prices for orphan drugs slam families and insurers

Sky-high prices for orphan drugs slam families and insurers

By Sarah Jane Tribble and Sydney Lupkin Photos by Heidi de Marco Kaiser Health News Before Luke Whitbeck began taking a $300,000-a-year drug, the 2-year-old’s health was inexplicably failing. A pale boy with enormous eyes, Luke frequently ran high fevers, tired easily and was skinny all over, except his belly stuck out like a bowling […]

January 18, 2017 | By | Reply More
Trump’s HHS nominee Tom Price got sweetheart deal from foreign biotech firm

Trump’s HHS nominee Tom Price got sweetheart deal from foreign biotech firm

By Jay Hancock and Rachel Bluth Kaiser Health News When tiny Australian biotech firm Innate Immunotherapeutics needed to raise money last summer, it didn’t issue stock on the open market. Instead, it offered a sweetheart deal to “sophisticated U.S. investors,” company documents show. It sold nearly $1 million in discounted shares to two American congressmen […]

January 13, 2017 | By | 1 Reply More
Telemedicine in schools helps keep kids in the classroom

Telemedicine in schools helps keep kids in the classroom

By Michael Ollove Stateline ELKRIDGE, Md. — In late November, on the first cold morning of the season, a second-grader at Ducketts Lane Elementary School had trouble breathing during recess. When the school nurse, Veronica DeSimone, examined the girl, she heard wheezing in her chest and noted her low oxygen levels. DeSimone determined that the […]

January 4, 2017 | By | 2 Replies More
Medicare pays for a kidney transplant, but not the drugs to keep it viable

Medicare pays for a kidney transplant, but not the drugs to keep it viable

By Richard Harris, NPR News Kaiser Health News The federal government will pay more than $100,000 to give someone a kidney transplant, but after three years, the government will often stop paying for the drugs needed to keep that transplanted kidney alive. Constance Creasey is one of the thousands of people who find themselves caught […]

December 24, 2016 | By | Reply More